Table 3 “ Peptides from the top quartile (3-48) were compared to peptides from the 2nd (24,897—24,944) and 3rd (74,655—74,680) quartiles. Columns headings: peptide ID indicates the control Bac2A or the test peptide by rank number. Columns give MIC values in “M and g/mL in parentheses, measured in 3—5 replicates for A, P. aeruginosa wild type strain H103; B, C, D, P. aeruginosa multidrug-resistant strains from Brazil 9, 198, and 213, respectively; E, F, G, P. aeruginosa Liverpool epidemic strains LES400, H1030, and H1027, respectively; H, P. maltophilia ATCC13637; I, constitutive class C chromosomal /3-lactamase expressing E. cloacae 218R; J, K, extended-spectrum /-lactamase-producing (ESBL) E. coli (clinical strains 63103 and 64771); L, M, ESBL-resistant K. pneumonia (clinical strains 61962 and 63575); N, S. aureus ATCC25923; O, methicillin- resistant S. aureus strain C623; P, E. faecalis ATCC29212; Q, R, vancomycin-resistant E. faecalis [clinical isolates w61950 (VanA) and £43559 (VanB)]; S,T, vancomycin-resistant E. faecium [clinical isolates mic80 (VanA) and t62764 (VanB)]. Table 3. Activities against Multiresistant Superbugs of Selected Peptides Predicted through QSAR Analysis Compared to the Peptide Bac2A“